Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Opko Health Inc (NQ: OPK ) 1.490 -0.030 (-1.97%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Opko Health Inc TechMediaBreaks – NextPlat Corp (NASDAQ: NXPL) Expands E-Commerce Program in China July 02, 2024 Via Investor Brand Network 2 penny stocks insiders are buying February 27, 2024 Penny stocks come with outsized risks, but some risks can be mitigated by following the insiders. Insiders aren't going to waste good money on a bad company. Via MarketBeat These are the 4 hottest stocks insiders bought in January January 29, 2024 Insiders are buying these stocks, but not all are good buys for investors or bullish traders; avoid stocks with high short interest, no revenue, and no earnings Via MarketBeat NextPlat latest financial numbers shows double-digit growth in e-commerce and healthcare division November 15, 2023 Charlie Fernandez, CEO of NextPlat, provided an update on the company's latest financial results during an interview with Steve Darling from Proactive. Via TheNewswire.com BioMedNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Launch of OPKO Health Inc. (NASDAQ: OPK)-Branded Online Storefront October 12, 2023 Via Investor Brand Network NextPlat's Florida E-Commerce Development Program to Launch the Online Sales of OPKO Healthcare Products in China on Alibaba's Tmall Global October 12, 2023 Via ACCESSWIRE MarketBeat Week in Review – 7/17 - 7/21 July 22, 2023 Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks Via MarketBeat Topics Economy Exposures Economy Interest Rates OPKO Health is the Little Giant of Diversified Healthcare July 19, 2023 Diversified healthcare company OPKO Health Inc. (NASDAQ: OPK) shares may be low priced, but its businesses pipeline of treatments and upside potential may Via MarketBeat Topics Intellectual Property Exposures COVID-19 Intellectual Property FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency June 28, 2023 From Pfizer Inc. Via Business Wire Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency February 15, 2022 From Pfizer Inc. Via Business Wire Rising Incidence of Pancreatic Cancer Driving Demand for Advanced Treatment Therapies November 07, 2022 Palm Beach, FL – November 7, 2022 – FinancialNewsMedia.com News Commentary – While there is no cure for pancreatic cancer in the pancreatic cancer treatment market, new treatment options abound, and... Via FinancialNewsMedia Exposures COVID-19 Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency January 21, 2022 From Pfizer Inc. Via Business Wire OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference January 05, 2022 From OPKO Health, Inc. Via Business Wire Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program August 26, 2021 From Rite Aid Corporation Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.